Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial (vol 29, pg 3120, 2023)

被引:2
|
作者
Mautner, Ken
Gottschalk, Michael
Boden, Scott D.
Akard, Alison
Bae, Won C.
Black, Lora
Boggess, Blake
Chatterjee, Paramita
Chung, Christine B.
Easley, Kirk A.
Gibson, Greg
Hackel, Josh
Jensen, Katie
Kippner, Linda
Kurtenbach, Chad
Kurtzberg, Joanne
Mason, R. Amadeus
Noonan, Benjamin
Roy, Krishnendu
Valentine, Verle
Yeago, Carolyn
Drissi, Hicham
机构
[1] Emory University,Department of Orthopaedics
[2] University of California,Department of Radiology
[3] Davis,Marcus Center for Therapeutic Cell Characterization and Manufacturing
[4] Sanford Health,Department of Biostatistics and Bioinformatics
[5] Duke Sports Medicine,Center for Integrative Genomics
[6] Georgia Institute of Technology,Marcus Center for Therapeutic Cures
[7] Emory University,Biomedical Engineering
[8] Georgia Institute of Technology,undefined
[9] Andrews Institute,undefined
[10] Duke University,undefined
[11] Sanford Health,undefined
[12] Vanderbilt University,undefined
关键词
D O I
10.1038/s41591-023-02776-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:905 / 905
页数:1
相关论文
共 50 条
  • [31] Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401 (vol 29, 4784, 2023)
    Chung, David J.
    Shah, Nina
    Wu, Juan
    Logan, Brent
    Bisharat, Lina
    Callander, Natalie
    Cheloni, Giulia
    Anderson, Kenneth
    Chodon, Thinle
    Dhakal, Binod
    Devine, Steve
    Dutt, Poorvi Somaiya
    Efebera, Yvonne
    Geller, Nancy
    Ghiasuddin, Haider
    Hematti, Peiman
    Holmberg, Leona
    Howard, Alan
    Johnson, Bryon
    Karagkouni, Dimitra
    Lazarus, Hillard M.
    Malek, Ehsan
    McCarthy, Philip
    McKenna, David
    Mendizabal, Adam
    Nooka, Ajay
    Munshi, Nikhil
    O'Donnell, Lynn
    Patel, Krina
    Rapoport, Aaron P.
    Reese, Jane
    Rosenblatt, Jacalyn
    Soiffer, Robert
    Stroopinsky, Dina
    Uhl, Lynne
    Vlachos, Ioannis S.
    Waller, Edmund K.
    Young, James W.
    Pasquini, Marcelo C.
    Avigan, David
    CLINICAL CANCER RESEARCH, 2024, 30 (19) : 4542 - 4542
  • [32] Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial (vol 378, pg 1931, 2011)
    Rini, B., I
    Escudier, B.
    Tomczak, P.
    LANCET, 2012, 380 (9856): : 1818 - 1818
  • [33] Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results (vol 29, pg 127, 2018)
    Aparicio, T.
    Bouche, O.
    Taieb, J.
    Maillard, E.
    Kirscher, S.
    Etienne, P. -L
    Faroux, R.
    Akouz, F. Khemissa
    El Hajbi, F.
    Locher, C.
    Rinaldi, Y.
    Lecomte, T.
    Lavau-Denes, S.
    Baconnier, M.
    Oden-Gangloff, A.
    Genet, D.
    Paillaud, E.
    Retornaz, F.
    Francois, E.
    Bedenne, L.
    ANNALS OF ONCOLOGY, 2018, 29 (11) : 2270 - 2270
  • [34] Clinical outcomes based on MET expression level in METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC)
    Powles, Thomas
    Escudier, Bernard
    Motzer, Robert J.
    Tannir, Nizar M.
    Scheffold, Christian
    Aftab, Dana T.
    Chouieri, Toni K.
    BJU INTERNATIONAL, 2016, 118 : 4 - 4
  • [35] "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" (vol 29, pg no 918-923, 2023)
    Barda, Noam
    Lustig, Yaniv
    Indenbaum, Victoria
    Zibly, Daniel
    Joseph, Gili
    Asraf, Keren
    Weiss-Ottolenghi, Yael
    Amit, Sharon
    Kliker, Limor
    Abu-Kadar, Bian
    Ben-Ami, Eytan
    Canetti, Michal
    Koren, Ravit
    Katz-Likvornik, Shiri
    Halpern, Osnat
    Mendelson, Ella
    Doolman, Ram
    Harats, Dror
    Kreiss, Yitshak
    Mandelboim, Michal
    Regev-Yochay, Gili
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (03) : 409 - 413
  • [36] Cognitive functional therapy with orwithout movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial. Lancet 2023 (vol 401, pg 1866, 2023)
    Kramer, Caroline K.
    Leitao, Cristiane B.
    Viana, Luciana V.
    LANCET, 2023, 401 (10393): : 2040 - 2040
  • [37] Day hospital versus intensive outpatient mentalization-based treatment: 3-year follow-up of patients treated for borderline personality disorder in a multicentre randomized clinical trial (Vol 53, pg 605, 2023)
    Smits, Maaike L.
    Feenstra, Dine J.
    Bales, Dawn L.
    Blankers, Matthijs
    Dekker, Jack J. M.
    Lucas, Zwaan
    Kamphuis, Jan H.
    Busschbach, Jan J. V.
    Verheul, Roel
    Luyten, Patrick
    PSYCHOLOGICAL MEDICINE, 2023, 53 (02) : 605 - 608
  • [38] Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial (vol 41, pg 4632, 2023)
    Ling, Yiwen
    Xuan, Li
    Xu, Na
    Huang, Fen
    Fan, Zhiping
    Guo, Ziwen
    Xu, Xiaojun
    Liu, Hui
    Lin, Ren
    Yu, Sijian
    Zhang, Haiyan
    Jin, Hua
    Wu, Meiqing
    Liu, Can
    Liang, Xinquan
    Ou, Ruiming
    Zhang, Yuping
    Liu, Xiaodan
    Qu, Hong
    Zhai, Xiao
    Sun, Jing
    Zhao, Ying
    Liu, Qifa
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08) : 1045 - 1045
  • [39] CONCORDANCE OF BASELINE PAIN MEASURES (ACROSS TWO REPORTING INSTRUMENTS) INFLUENCES TREATMENT EFFECT: POST HOC ANALYSIS OF A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE IN PATIENTS WITH KNEE OSTEOARTHRITIS
    Conaghan, P. G.
    Ross, E.
    Kivitz, A.
    Turk, D. C.
    Spitzer, A. I.
    Jones, D. G.
    Lanier, R.
    Cinar, A.
    Lufkin, J.
    Kelley, S. D.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S492 - S493
  • [40] Concordance of Baseline Pain Measures (Across Two Reporting Instruments) Influences Treatment Effect: Post Hoc Analysis of a Phase 3 Randomized Controlled Trial of Triamcinolone Acetonide Extended-Release in Patients with Knee Osteoarthritis
    Conaghan, Philip G.
    Ross, Edgar
    Kivitz, Alan
    Turk, Dennis
    Spitzer, Andrew
    Jones, Deryk
    Lanier, Ryan
    Cinar, Amy
    Lufkin, Joelle
    Kelley, Scott
    ARTHRITIS & RHEUMATOLOGY, 2019, 71